PFA Pension Forsikringsaktieselskab Invests $16.36 Million in Kenvue Inc. $KVUE

Key Points

• PFA Pension opened a new position in Kenvue (NYSE:KVUE) in Q4, acquiring 944,278 shares valued at approximately $16.36 million.
• Institutional ownership is very high at 97.64%, with large managers—Vanguard, American Century, Dimensional, VanEck and Amundi—having recently increased their Kenvue stakes.
• Analysts mostly rate Kenvue as a "Hold" (average target $19.33) after several recent target cuts, and the company declared a quarterly dividend of $0.2075 (annualized yield ~4.8%) with an ex-dividend date of May 13.

PFA Pension Forsikringsaktieselskab acquired a new position in shares of Kenvue Inc. (NYSE:KVUE - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 944,278 shares of the company's stock, valued at approximately $16,364,000.

A number of other large investors have also modified their holdings of the company. Vanguard Group Inc. raised its stake in shares of Kenvue by 0.7% in the fourth quarter. Vanguard Group Inc. now owns 234,951,484 shares of the company's stock valued at $4,052,913,000 after purchasing an additional 1,604,040 shares in the last quarter. American Century Companies Inc. raised its stake in shares of Kenvue by 22.4% in the third quarter. American Century Companies Inc. now owns 37,046,660 shares of the company's stock valued at $601,267,000 after purchasing an additional 6,781,640 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Kenvue by 13.5% in the third quarter. Dimensional Fund Advisors LP now owns 23,127,234 shares of the company's stock valued at $375,377,000 after purchasing an additional 2,747,952 shares in the last quarter. Van ECK Associates Corp raised its stake in shares of Kenvue by 101.3% in the third quarter. Van ECK Associates Corp now owns 18,361,581 shares of the company's stock valued at $298,008,000 after purchasing an additional 9,240,434 shares in the last quarter. Finally, Amundi raised its stake in shares of Kenvue by 21.6% in the third quarter. Amundi now owns 17,645,761 shares of the company's stock valued at $277,012,000 after purchasing an additional 3,135,871 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of brokerages recently commented on KVUE. UBS Group cut their target price on Kenvue from $19.00 to $18.00 and set a "neutral" rating for the company in a research note on Tuesday, April 7th. Weiss Ratings restated a "hold (c-)" rating on shares of Kenvue in a research note on Wednesday, April 8th. Argus upgraded Kenvue to a "hold" rating in a research note on Friday, March 6th. Barclays cut their target price on Kenvue from $19.00 to $18.00 and set an "equal weight" rating for the company in a research note on Tuesday, April 14th. Finally, Citigroup cut their target price on Kenvue from $20.00 to $19.00 and set a "neutral" rating for the company in a research note on Wednesday, April 15th. Three investment analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the stock. According to MarketBeat.com, Kenvue presently has an average rating of "Hold" and an average target price of $19.33.

Kenvue Stock Performance

Shares of NYSE:KVUE opened at $17.44 on Monday. The business's fifty day moving average price is $17.72 and its two-hundred day moving average price is $17.19. Kenvue Inc. has a fifty-two week low of $14.02 and a fifty-two week high of $25.17. The stock has a market capitalization of $33.48 billion, a price-to-earnings ratio of 22.65, a price-to-earnings-growth ratio of 3.96 and a beta of 0.55. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.96 and a quick ratio of 0.68.

Kenvue (NYSE:KVUE - Get Free Report) last announced its quarterly earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share for the quarter, beating analysts' consensus estimates of $0.22 by $0.05. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.The firm had revenue of $3.78 billion for the quarter, compared to analysts' expectations of $3.68 billion. During the same period in the prior year, the business posted $0.26 earnings per share. The business's revenue was up 3.2% compared to the same quarter last year. As a group, analysts predict that Kenvue Inc. will post 1.1 EPS for the current fiscal year.

Kenvue Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 27th. Shareholders of record on Wednesday, May 13th will be given a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a yield of 4.8%. The ex-dividend date is Wednesday, May 13th. Kenvue's dividend payout ratio is 107.79%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.

Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.